相关实验视频

Updated: Jun 17, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

干白素-21工程通过CEBPD增强NK细胞对抗质母细胞瘤的活性

Mayra Shanley¹, May Daher¹, Jinzhuang Dou²

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

|August 13, 2024

概括

与IL-15NK细胞相比,Interleukin-21 (IL-21) 改造的自然杀手 (NK) 细胞对质母细胞瘤具有更高的安全性和抗瘤活性. IL-21通过通过C/EBP转录因子进行表观遗传重编程来增强NK细胞功能.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑癌.
自然杀手 (NK) 细胞具有先天的抗瘤特性,正在被探索为GBM的治疗策略.
目前对GBM的治疗选择有限,需要新的治疗方法.

研究的目的:

为了比较NK细胞的疗效和安全性,这些NK细胞被改造以表达IL-21或IL-15,用于治疗GBM.
调查潜在的分子机制,包括转录因子参与和表观遗传修饰,驱动IL-21工程NK细胞的抗GBM活性.

主要方法:

产生表达IL-15或IL-21的工程NK细胞,并在多个体内GBM模型中进行了生成和测试.
对IL-21NK细胞进行了染色体可访问性分析,以确定关键的调控转录因子.
通过基因删除和过度表达研究,评估了CCAAT/增强剂结合蛋白 (C/EBP) 的作用,特别是CEBPD.

主要成果:

与IL-21NK细胞相比,IL-21NK细胞在体内表现出优越的抗瘤活性和改善的安全性,而IL-15NK细胞则表现出更好的安全性.
局部给予IL-15NK细胞导致毒性,缺乏有效的瘤控制.
IL-21 NK细胞表现出由C/EBP转录因子调节的独特的染色质可访问性特征,CEBPD对于增强NK细胞功能,细胞毒性和代谢适应性至关重要.

结论:

经IL-21工程的NK细胞代表了质母细胞瘤的一种有前途的治疗策略,在有效性和安全性上都超过了IL-15工程的NK细胞.
转录因子CEBPD在调解IL-21NK细胞增强的抗GBM功能方面发挥着至关重要的作用.
IL-21诱导NK细胞的表观遗传重编程,从而改善抗瘤功效和代谢适应性,为GBM免疫疗法提供了一条新的途径.

关键词:

在 CEBPD 工作, CEBPD 的工作是:在GBMGBMGBMGBMGBM 它们是IL-21和IL-21.在 NK 细胞中,NK 细胞是 NK 细胞.

更多相关视频

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

相关概念视频

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.